Open AccessIbrutinib (Imbruvica®) for cGVHD
Author(s) -
Adam Melaragno
Publication year - 2018
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000546350.67540.7b
Subject(s) - ibrutinib , bruton's tyrosine kinase , medicine , mantle cell lymphoma , chronic lymphocytic leukemia , tolerability , oncology , immunology , tyrosine kinase , cancer research , lymphoma , leukemia , adverse effect , receptor